News
GlaxoSmithKline Pharmaceuticals is a subsidiary of the GSK Group in India. Its objective is to get ahead of disease with the ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
Hosted on MSN10mon
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial rulingFor example, in Florida, a federal judge dismissed about 50,000 lawsuits against the company. Last month, in the first case to go before a jury, GSK and one of its peers won a case in Illinois.
reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10(b) ...
The firm owned 17,050 shares of the pharmaceutical company’s stock after buying an additional 1,964 shares during the period. Independent Advisor Alliance’s holdings in GSK were worth $577,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results